Inventor profile of:

Eric Sievers

City:

Bothell, Washington

Country:

United States

Published Applications:

17

Last publication date:

2024-12-19

Top Assignees for applications by Eric Sievers

The entities that hold a legal rights for patent applications filed by inventor Sievers Eric:

Recent patent applications by Sievers Eric

Eric Sievers from Bothell, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-12-19
US20240415917A1
Human necessities

WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES

#2 | 2024-05-02
US20240139275A1
Human necessities

WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES

#3 | 2022-09-15
US20220288152A1
Human necessities

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

#4 | 2021-10-14
US20210315962A1
Human necessities

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

#5 | 2021-05-13
US20210138020A1
Human necessities

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

#6 | 2020-10-01
US20200306336A1
Human necessities

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

#7 | 2020-01-30
US20200030405A1
Human necessities

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

#8 | 2019-07-25
US20190224268A1
Human necessities

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

#9 | 2018-12-27
US20180369317A1
Human necessities

Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates

#10 | 2017-10-05
US20170281794A1
Human necessities

Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates

#11 | 2016-05-12
US20160129130A1
Human necessities

Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates

#12 | 2013-01-24
US20130022627A1
Chemistry; metallurgy

Combination therapy with antibody-drug conjugates

#13 | 2011-11-03
US20110268751A1
Human necessities

Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates

#14 | 2011-02-17
US20110038856A1
Chemistry; metallurgy

METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES

#15 | 2010-08-26
US20100215671A1
Chemistry; metallurgy

Combination therapy with antibody-drug conjugates

#16 | 2010-08-26
US20100215653A1
Chemistry; metallurgy

METHODS OF TREATING NEOPLASTIC, AUTOIMMUNE AND INFLAMMATORY DISEASES

#17 | 2008-10-30
US20080267960A1
Chemistry; metallurgy

Methods of treating neoplastic, autoimmune and inflammatory diseases

InventorID:

52472 ⎘